Matthew Royle, Tim Worden and Paul England discuss issues raised by Brexit for medicinal product and medical device authorisation and exclusivity rights.

They cover the key developments in this area since their webinar of 14 February 2017, including the latest position papers, and news on the EMA and the UPC.

Click here to view video.